IJGC Podcast

Outcomes of Ultra-radical Surgery in Ovarian Cancer with Sahar Salehi

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Sr. Sahar Salehi to discuss outcomes of ultra-radical surgery in ovarian cancer. Dr. Salehi is the Director of ovarian cancer surgery at Karolinska University Hospital, in Stockholm, Sweden, as well as an Assistant Professor at the Department of Microbiology, Tumor and Cellbiology at Karolinska Institutet.
• A shift to ultra-radical surgery does not improve survival despite increased complete resection rates, for this reason complete resection may not be the absolute aim in a high surgical proficiency setting.
• A shift to ultra-radical surgery increase the proportion of non-surgically treated women.
• The majority of women with cancer in the abdomen of unknown origin (inoperabel/non-resectable women/women who might not meet a gynecologic oncologist) are ovarian cancer patients.
• There is an urgent need to calibrate selection of patients to surgery (and to which extent of surgery) in more detail.

Reviewing the November Issue with Sadie Jones and Navya Nair (English Version)

In this issue of the IJGC Podcast, Editorial Fellows Sadie Jones and Navya Nair discuss the contents of the November issue of IJGC.

Results of the SCORPION Trial with Anna Fagotti

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Anna Fagotti to discuss the results of the SCORPION trial. Dr. Fagotti is the lead author of "Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)", which is the Lead Article of IJGC’s November 2020 issue (https://ijgc.bmj.com/content/early/2020/10/07/ijgc-2020-001640).
Dr. Fagotti is the Ovarian Cancer Unit Director at Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome, Italy, as well as an Associate Professor of Obstetrics and Gynecology at Università Cattolica del Sacro Cuore. Additionally, she is PhD Faculty of Biotechnology at University of Perugia, ESGO Council Member and Chair of the Educational Committee, as well as an Associate Editor for IJGC.
Highlights:
1. PDS and NACT ± IDS have superimposable median PFS and OS in patients with HTL ovarian cancer.
2. PDS has a higher rate of postoperative complications than IDS.
3. RT is the most powerful prognostic factor in AOC patients both at PDS and IDS"

Postoperative Complications of Epidural Analgesia with Sarah Ackroyd

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Sarah Ackroyd to discuss postoperative complications of epidural analgesia. Dr. Sarah Ackroyd is a gynecologic oncology fellow at the University of Chicago. Her research interests include health economics and outcomes research with a focus on decision analysis and patient-centered medical decision making. Dr. Sarah Ackroyd is a gynecologic oncology fellow at the University of Chicago. Her research interests include health economics and outcomes research with a focus on decision analysis and patient-centered medical decision making.
Main points:
- Our study utilizing the NSQIP database found that in a cohort of >2,000 patients who received an epidural at time of hysterectomy for cancer, there was a ~14% higher rate of minor complications including blood transfusions and superficial wound infection.
- Challenges of the epidural including hypotension and related complications, may be explained by the medication-induced sympathetic block that primarily prevents pain perception but can affect other sympathetic functions.J45
- Other studies in Gyn Oncology that utilized the epidural in an ERAS protocol demonstrate an overall improvement in postoperative pain scores, K43decreased opioid use, and no major complications.
- In the appropriate patient with the above findings considered, regional anesthesia such as the epidural, should be considered as part of a multi-modal pain approach.

Sexual Harassment in Gynecologic Oncology with Marina Stasenko

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Marina Stasenko to discuss sexual harassment in gynecologic oncology. Dr. Stasenko is a practicing gynecologic oncologist at the NYU Langone Hospital and recently completed her fellowship at the Memorial Sloan Kettering Cancer Center.
Highlights from the podcast:
- 64% of all gynecologic oncologist surveyed reported experience of sexual harassment in training or in practice.
- Only 14.5% reported the behavior.
- Female respondents were more likely to report that gender affected their career and compensation.
- Male respondents were more likely to report no gender disparity in income.

Reviewing the October Issue with Florencia Noll (Spanish Version)

In this episode of the IJGC Podcast, Florencia Noll discusses the contents of the October issue of IJGC in Spanish.

Reviewing the October Issue with Sadie Jones and Navya Nair (English Version)

In this issue of the IJGC Podcast, Editorial Fellows Sadie Jones and Navya Nair discuss the contents of the October issue of IJGC.

Impact of Uterine Manipulator in Endometrial Cancer with Pablo Padilla-Iserte

Pablo Padilla-Iserte, MD, PhD, is a gynecologic oncologist working at the Department of Gynecologic Oncology. La Fe University and Polytechnic Hospital, Valencia (Spain), ESGO Accredited Center. She specializes in oncological surgery, especially in minimally invasive approach and education programs for fellowship and residents.

ERAS Global Survey with Gregg Nelson and Geetu Bhandoria

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Gregg Nelson and Geetu Bhandoria to discuss the ERAS Global Survey. Their article, "Enhanced Recovery After Surgery (ERAS) in gynecologic oncology: an international survey of peri-operative practice” (https://ijgc.bmj.com/content/early/2020/08/28/ijgc-2020-001683), is the Lead Article in the October 2020 of IJGC.
Dr. Gregg Nelson is Professor and Chief of Gynecologic Oncology at the Tom Baker Cancer Centre in Calgary, Alberta, Canada. His main research interest is the development and study of Enhanced Recovery After Surgery (ERAS) protocols in cancer and ObGyn surgery. Dr. Nelson is Secretary of the ERAS Society.
Dr. Geetu Bhandoria is a Gynecologic Oncologist and obstetrician at Command Hospital in Pune, India. He as completed fellowship in Gynecologic Oncology. His research interests are advanced ovarian cancer, enhanced recovery protocols and the use of social media as a research tool. He is also currently serving as one of IJGC’s Editorial Fellows.

Hospital Volume and Outcomes in Early Cervical Cancer with Emeline Aviki

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Emeline Aviki to discuss hospital volume and outcomes in early cervical cancer. Dr. Emeline Aviki, MD, MBA is a Gynecologic Oncologist at Memorial Sloan Kettering Cancer Center and former research fellow in the health outcomes research group at MSKCC. Dr. Aviki's research focus is in health outcomes and care delivery innovation to improve the affordability of care for patients.